Wetter Pharma-Vertrieb GmbH & Co. KG (manufacturing of medicinal product, primary packaging of bulk pre-filled syringes, testing (sterility and bacterial endotoxins); secondary packaging of bulk pre-filled syringes, testing (sterility and bacterial endotoxins))

Ukraine

All drugs from this manufacturer

  • HUMIRA

    The drug is prescribed for the treatment of polyarticular juvenile idiopathic arthritis, enthesitis-associated arthritis, Crohn's disease, plaque psoriasis, and chronic non-infectious anterior uveitis in children.

    Dosage form: solution for injection

    Active substance Dosage
    adalimumab 20 mg 0.2 ml

    ATC: L04AB04

  • The drug is prescribed for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (axial spondyloarthritis), Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is also used in children for juvenile forms of arthritis and other conditions specified in the indications.

    Dosage form: solution for injection

    Active substance Dosage
    adalimumab 40 mg/0.4 mL

    ATC: L04AB04